Position in ELAN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$4,651
+$129 QoQ
Shares Held
189
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#447
of 515 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026J.Safra Asset Management Corp holds $752,734 across 7 Drug Manufacturers - Specialty & Generic names. ELAN ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
19,204 | $650,631 | |
| 2 | ZTS |
Zoetis Inc.
|
685 | $49,224 | |
| 3 | VTRS |
Viatris Inc
|
1,247 | $19,802 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
128 | $14,200 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
134 | $8,569 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
315 | $5,657 | |
| 7 | ELAN |
Elanco Animal Health Inc
This page
|
189 | $4,651 |
All Filings in ELAN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,651 | 189 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $4,522 | 189 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,855 | 82 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,202 | 159 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $13,366 | 936 | Shares | Sole | 2025-10-29 | |
| 2025-03-31 | $14,007 | 1,334 | Shares | Sole | 2025-10-29 | |
| 2024-12-31 | $14,883 | 1,229 | Shares | Sole | 2025-02-06 | |
| No filing history on record for this holder in this stock. | ||||||